Pfam Domains GO Terms
| UQ con |
| negative regulation of retrograde protein transport, ER to cytosol |
| negative regulation of protein exit from endoplasmic reticulum |
| negative regulation of ERAD pathway |
| regulation of retrograde protein transport, ER to cytosol |
| cellular response to interferon-beta |
| regulation of protein exit from endoplasmic reticulum |
| response to interferon-beta |
| regulation of ERAD pathway |
| protein N-linked glycosylation via asparagine |
| peptidyl-asparagine modification |
| ubiquitin conjugating enzyme activity |
| negative regulation of intracellular protein transport |
| negative regulation of response to endoplasmic reticulum stress |
| protein K48-linked ubiquitination |
| negative regulation of proteasomal protein catabolic process |
| negative regulation of intracellular transport |
| ubiquitin-dependent ERAD pathway |
| negative regulation of proteolysis involved in cellular protein catabolic process |
| protein N-linked glycosylation |
| regulation of response to endoplasmic reticulum stress |
| negative regulation of cellular protein catabolic process |
| ERAD pathway |
| negative regulation of cellular protein localization |
| negative regulation of protein catabolic process |
| negative regulation of protein transport |
| regulation of proteasomal protein catabolic process |
| negative regulation of establishment of protein localization |
| regulation of proteolysis involved in cellular protein catabolic process |
| regulation of intracellular protein transport |
| ubiquitin-protein transferase activity |
| regulation of cellular protein catabolic process |
| negative regulation of cellular catabolic process |
| macromolecule glycosylation |
| protein glycosylation |
| response to endoplasmic reticulum stress |
| glycosylation |
| protein polyubiquitination |
| negative regulation of catabolic process |
| glycoprotein biosynthetic process |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| proteasomal protein catabolic process |
| regulation of intracellular transport |
| negative regulation of proteolysis |
| regulation of protein catabolic process |
| glycoprotein metabolic process |
| negative regulation of transport |
| ubiquitin-dependent protein catabolic process |
| modification-dependent protein catabolic process |
| regulation of cellular protein localization |
| modification-dependent macromolecule catabolic process |
| proteolysis involved in cellular protein catabolic process |
| carbohydrate derivative biosynthetic process |
| cellular protein catabolic process |
| protein catabolic process |
| protein ubiquitination |
| regulation of protein transport |
| regulation of proteolysis |
| regulation of cellular response to stress |
| regulation of peptide transport |
| regulation of establishment of protein localization |
| protein modification by small protein conjugation |
| regulation of cellular catabolic process |
| peptidyl-amino acid modification |
| cellular macromolecule catabolic process |
| regulation of cellular localization |
| protein modification by small protein conjugation or removal |
| regulation of catabolic process |
| response to organonitrogen compound |
| cellular response to cytokine stimulus |
| endoplasmic reticulum |
| carbohydrate derivative metabolic process |
| regulation of protein localization |
| negative regulation of cellular protein metabolic process |
| macromolecule catabolic process |
| organonitrogen compound catabolic process |
| identical protein binding |
| response to nitrogen compound |
| response to cytokine |
| negative regulation of protein metabolic process |
| proteolysis |
| organonitrogen compound biosynthetic process |
| regulation of response to stress |
| ATP binding |
| negative regulation of response to stimulus |
| cellular response to stress |
| cellular macromolecule biosynthetic process |
| macromolecule biosynthetic process |
| organic substance catabolic process |
| cellular catabolic process |
| regulation of transport |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| FAF2 | 0.671 |
| DOHH | 0.611 |
| RPTOR | 0.601 |
| AUP1 | 0.599 |
| UBE2J1 | 0.582 |
| DNAJC3 | 0.578 |
| ATP5O | 0.573 |
| ROMO1 | 0.563 |
| THG1L | 0.557 |
| PMM2 | 0.556 |
| MANF | 0.554 |
| PLAA | 0.553 |
| ATP5J | 0.552 |
| RNMT | 0.55 |
| ALG5 | 0.544 |
| ATP5A1 | 0.54 |
| GFPT1 | 0.537 |
| TRIAP1 | 0.535 |
| DPAGT1 | 0.534 |
| ALG1 | 0.534 |
| UAP1 | 0.534 |
| CBFB | 0.529 |
| ATP5B | 0.527 |
| ENY2 | 0.524 |
| WDR24 | 0.522 |
| HSPD1 | 0.517 |
| SRP14 | 0.514 |
| TMED10 | 0.513 |
| SEC62 | 0.511 |
| DOLK | 0.508 |
| DERL2 | 0.504 |
| BAP1 | 0.504 |
| OPA1 | 0.503 |
| ELP3 | 0.502 |
| CTDNEP1 | 0.501 |
| KDSR | 0.5 |
| PPP2R3C | 0.499 |
| GTF3C4 | 0.498 |
| SUV420H1 | 0.498 |
| ID3 | 0.497 |
| GMPPB | 0.497 |
| ALG6 | 0.497 |
| UBA5 | 0.491 |
| MTOR | 0.491 |
| CRLS1 | 0.49 |
| NSD1 | 0.49 |
| CCDC101 | 0.488 |
| UFM1 | 0.486 |
| RTCB | 0.482 |
| TRIM28 | 0.482 |
| DNAJB11 | 0.481 |
| TAZ | 0.48 |
| SEC63 | 0.478 |
| ATP5I | 0.478 |
| TAF4 | 0.477 |
| GNB1L | 0.477 |
| ATP5D | 0.476 |
| STT3A | 0.476 |
| SSB | 0.475 |
| ALG13 | 0.474 |
| MED16 | 0.473 |
| APAF1 | 0.471 |
| UFC1 | 0.47 |
| VMP1 | 0.469 |
| XPO6 | 0.467 |
| EXOC4 | 0.466 |
| UBE2M | 0.464 |
| DHRSX | 0.462 |
| CASP9 | 0.461 |
| TIMM13 | 0.46 |
| GTF3C6 | 0.459 |
| PPA2 | 0.458 |
| BAK1 | 0.457 |
| VHL | 0.456 |
| C1orf27 | 0.455 |
| LAMTOR4 | 0.455 |
| IRF2BP2 | 0.452 |
| TRMT10A | 0.451 |
| ADSL | 0.451 |
| DERL1 | 0.45 |
| MLLT1 | 0.449 |
| TMEM41B | 0.448 |
| SMG9 | 0.447 |
| DAD1 | 0.446 |
| CEPT1 | 0.445 |
| RPP21 | 0.444 |
| CYCS | 0.442 |
| UHRF1 | 0.441 |
| SLC25A26 | 0.441 |
| URM1 | 0.44 |
| ATXN10 | 0.439 |
| TAMM41 | 0.437 |
| PGGT1B | 0.436 |
| ATP5H | 0.436 |
| BCS1L | 0.432 |
| UBE2K | 0.432 |
| MBTPS2 | 0.432 |
| HCCS | 0.431 |
| LSM11 | 0.43 |
| EIF4E | 0.43 |
| UBQLN1 | 0.429 |
| ATP2A2 | 0.426 |
| AARS | 0.426 |
| NAE1 | 0.425 |
| DR1 | 0.425 |
| ALG9 | 0.425 |
| DIABLO | 0.425 |
| LSMD1 | 0.424 |
| ATP5L | 0.422 |
| ATP5C1 | 0.421 |
| VDAC2 | 0.419 |
| TTI2 | 0.419 |
| TIMM22 | 0.418 |
| UTP23 | 0.418 |
| ALG2 | 0.416 |
| TLE4 | 0.414 |
| RPE | 0.413 |
| EED | 0.413 |
| TRNT1 | 0.412 |
| FH | 0.412 |
| CMTR1 | 0.411 |
| RAD23B | 0.411 |
| SERF2 | 0.41 |
| PELO | 0.41 |
| SLC35B1 | 0.407 |
| CHKA | 0.406 |
| SUPV3L1 | 0.406 |
| BTAF1 | 0.406 |
| DPF2 | 0.403 |
| GTF2A2 | 0.403 |
| DENND4A | 0.402 |
| GTF3C3 | 0.402 |
| PDAP1 | 0.402 |
| CDIPT | 0.402 |
| UBA3 | 0.401 |
| SEC61B | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 2/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 2/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 1/20 |
| lung | 2/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 5/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Expression Distribution